Page last updated: 2024-10-31

metoprolol and Acute Promyelocytic Leukemia

metoprolol has been researched along with Acute Promyelocytic Leukemia in 1 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Research Excerpts

ExcerptRelevanceReference
"Arsenic trioxide has become the treatment of choice for patients with acute promyelocytic leukaemia."1.37Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia. ( Ducas, J; Ducas, RA; Seftel, MD; Seifer, C, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ducas, RA1
Seftel, MD1
Ducas, J1
Seifer, C1

Other Studies

1 other study available for metoprolol and Acute Promyelocytic Leukemia

ArticleYear
Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia.
    The journal of the Royal College of Physicians of Edinburgh, 2011, Volume: 41, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiogra

2011